Zevra Therapeutics Ownership & Insider Activity

Zevra Therapeutics (ZVRA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.8% of shares outstanding. Institutional investors hold 44.6%. Over the past 90 days, insiders made 1 sale worth $475K.

Shares Outstanding

59.384M

Shares Float

58.706M

Insider Shares Owned

1.077M

Insider % Owned

1.8%

Institutional Shares Held

26.459M

Institutional % Held

44.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$475K total

Net Activity

Net Selling

Net Value (90d)

-$475K

Zevra Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 10, 2026	Neil F McFarlane	PRESIDENT AND CEO	SELL-OPTIONS	30.000K	$11.25	$225K
Aug 14, 2026	Rahsaan Thompson	CHIEF LEGAL & COMPLIANCE	SELL	42.666K	$11.13	$475K
Aug 10, 2026	Corey M. Watton	DIRECTOR	SELL-OPTIONS	—	$8.11	$77K
Jun 21, 2026	Rahsaan Thompson	CHIEF LEGAL & COMPLIANCE	SELL-OPTIONS	32.110K	$12.68	$438K
May 11, 2026	Rahsaan Thompson	CHIEF LEGAL & COMPLIANCE	SELL	1.794K	$11.30	$20K